34 results on '"Dumont, Anael"'
Search Results
2. Assessment of Social Deprivation and Socioeconomic Factors in Patients with Giant Cell Arteritis
3. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
4. Frequency and characteristics of severe relapses in giant cell arteritis
5. Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014–2017 and 2018–2020)
6. VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease
7. Thyroid disorders in familial Mediterranean fever: think about AA amyloidosis!
8. Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control study
9. Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement
10. Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement
11. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients
12. An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database
13. Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis
14. Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events
15. Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment Study
16. ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature
17. Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events.
18. Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review
19. Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review
20. Giant cell arteritis-related aortic dissection: A multicenter retrospective study
21. Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertise
22. Typical Familial Mediterranean Fever associated with the heterozygous missense sequence p.T577N variant of the MEFV gene: Report on two Northern European Caucasians relatives in France
23. Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study
24. Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis
25. Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement
26. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis
27. Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
28. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
29. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients
30. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
31. Evolution and outcomes of aortic dilations in giant cell arteritis.
32. Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events.
33. Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement.
34. The different clinical patterns of giant cell arteritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.